ZYCUBO FDA approval date

The FDA approved ZYCUBO on 12 Jan 2026.

FDA approval date
12 Jan 2026

Drug identity has not yet been verified against registry records

Also recorded as COPPER HISTIDINATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-01-12DayZYCUBOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211241", "applicant_as_listed_by_fda": "SENTYNL THERAPS INC", "brand_names": ["ZYCUBO"], "active_ingredients": ["COPPER HISTIDINATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260112", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026